Chronic wound healing composition and application thereof
OwnerHsu En LOinventor
Life of this patent
Estimating the term…
Abstract
A composition with efficacies of improving chronic wound healing, particularly diabetic wound healing, mainly selected from the group consisting of combinations of at least two of the following three components: (1) an anti-inflammatory agent selected from the group consisting of acteoside, isoacteoside and a combination thereof, (2) an astringent selected from the group consisting of gallic acid, subgallic acid, their salts and a combination thereof, and (3) a cooling agent selected from the group consisting of borneal, menthol and a combination thereof, and optionally combined with one or more pharmaceutically acceptable carriers. The present invention also provides use of said composition in the preparation of a medicament for treating a chronic wound, particularly a diabetic wound.
Claims12
A method for treating a diabetic wound, comprising:
- administering to a subject in need thereof an effective amount of a pharmaceutical composition comprising:
- (1) acteoside;
- (2) bismuth subgallate;
- and
- (3) borneol;
- optionally in combination with one or more pharmaceutically acceptable carriers, wherein the molar equivalent ratio of the three components (1):(2):(3) is 1:0.1-10:0.1-10.
A method for treating a diabetic wound, comprising:
- administering to a subject in need thereof an effective amount of a pharmaceutical composition consisting essentially of:
- (1) acteoside;
- (2) bismuth subgallate;
- and
- (3) borneol;
- optionally in combination with one or more pharmaceutically acceptable carriers, wherein the molar equivalent ratio of the three components (1):(2):(3) is 1:0.1-10:0.1-10.
Dependencies are inferred from the claim text.